In contrast, BMDC pulsing with melanoma cell lysates activated XBP1 splicing but not RIDD, and XBP1s appeared to promote, rather than disrupt, efficient melanoma antigen cross-presentation (Medel et al., 2018). This evidence concerns the gene XBP1 and melanoma.